Trials / Unknown
UnknownNCT03623451
Serum Metabolomics Study of Traditional Chinese Medicine Formula （Shen Qi Tiao Ti Formula） Intervention to Polycystic Ovary Syndrome
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- Heilongjiang University of Chinese Medicine · Academic / Other
- Sex
- Female
- Age
- 14 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Polycystic ovary syndrome (PCOS) is a most common, heterogeneous, complex endocrinopathy disease.Traditional Chinese medicine (TCM) has been used in the treatment of PCOS for many years. However, the mechanism underlying TCM remains obscure and challenging.In the present study, a metabolomics approach based on ultra-high-performance liquid chromatography (UPLC) coupled with linear ion trap Orbi-trap mass spectrometer (LTQ Orbi-trap MS) is used to investigate serum metabolic changes of TCM intervention to PCOS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chinese Medicine Formula | Chinese Medicine Formula, composed of American ginseng 10g, Poria cocos 15g, bighead atractylodes rhizome 20g, Astragalus mongholicus 30g, Crataegus pinnatifida Bunge 20g, Salvia miltiorrhiza Bge. 20g, Pericarpium Citri Reticulatae 10g will be decocted and packaged into vacuum packs by the pharmaceutical department of First Affiliated Hospital, Heilongjiang University of Chinese Medicine (140 mL/pack). Subjects will take 2 packages per day for three months. |
Timeline
- Start date
- 2018-08-10
- Primary completion
- 2019-08-31
- Completion
- 2020-06-30
- First posted
- 2018-08-09
- Last updated
- 2020-02-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03623451. Inclusion in this directory is not an endorsement.